Globus Medical - Stock Price History | GMED

Historical daily share price chart and data for Globus Medical since 2022 adjusted for splits. The latest closing stock price for Globus Medical as of October 03, 2022 is 60.85.
  • The all-time high Globus Medical stock closing price was 84.06 on September 08, 2021.
  • The Globus Medical 52-week high stock price is 81.78, which is 34.4% above the current share price.
  • The Globus Medical 52-week low stock price is 52.60, which is 13.6% below the current share price.
  • The average Globus Medical stock price for the last 52 weeks is 66.85.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Globus Medical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 71.9319 63.3400 84.0600 60.0500 72.2000 10.70%
2020 51.7100 59.4500 65.8700 35.0600 65.2200 10.77%
2019 47.6905 39.6100 59.5000 38.0800 58.8800 36.04%
2018 50.4504 43.1700 57.4400 41.3800 43.2800 5.30%
2017 31.0758 24.7900 41.6400 24.7900 41.1000 65.66%
2016 23.6585 26.7100 27.5900 20.6500 24.8100 -10.82%
2015 25.0363 23.7200 28.2400 20.6600 27.8200 17.04%
2014 22.6308 19.7500 26.9500 18.1400 23.7700 17.79%
2013 16.2303 10.9400 20.1800 10.8800 20.1800 92.37%
2012 14.7504 13.5000 18.7500 10.3700 10.4900 0.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.928B $0.958B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $198.711B 20.24
Edwards Lifesciences (EW) United States $51.226B 36.24
Alcon (ALC) Switzerland $28.513B 24.14
STERIS (STE) Ireland $16.630B 20.66
Teleflex (TFX) United States $9.450B 15.06
Fresenius Medical Care AG KGaA (FMS) Germany $8.228B 7.59
Penumbra (PEN) United States $7.184B 861.82
Glaukos (GKOS) United States $2.520B 0.00
Integer Holdings (ITGR) United States $2.061B 16.12
Nevro (NVRO) United States $1.649B 0.00
Paragon 28 (FNA) United States $1.368B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.031B 15.78
Artivion (AORT) United States $0.558B 53.23